These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 33667419)
41. FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT. Zhang X; Hu C; Kong CY; Song P; Wu HM; Xu SC; Yuan YP; Deng W; Ma ZG; Tang QZ Cell Death Differ; 2020 Feb; 27(2):540-555. PubMed ID: 31209361 [TBL] [Abstract][Full Text] [Related]
42. Curcumin attenuates doxorubicin-induced cardiotoxicity via suppressing oxidative stress and preventing mitochondrial dysfunction mediated by 14-3-3γ. He H; Luo Y; Qiao Y; Zhang Z; Yin D; Yao J; You J; He M Food Funct; 2018 Aug; 9(8):4404-4418. PubMed ID: 30063064 [TBL] [Abstract][Full Text] [Related]
44. Interleukin-33 attenuates doxorubicin-induced cardiomyocyte apoptosis through suppression of ASK1/JNK signaling pathway. Yao Y; Chen R; Ying C; Zhang G; Rui T; Tao A Biochem Biophys Res Commun; 2017 Nov; 493(3):1288-1295. PubMed ID: 28965952 [TBL] [Abstract][Full Text] [Related]
45. Polymorphisms to predict outcome to the tyrosine kinase inhibitors gefitinib, erlotinib, sorafenib and sunitinib. Erdem L; Giovannetti E; Leon LG; Honeywell R; Peters GJ Curr Top Med Chem; 2012; 12(15):1649-59. PubMed ID: 22978339 [TBL] [Abstract][Full Text] [Related]
46. Astragalus polysaccharide restores autophagic flux and improves cardiomyocyte function in doxorubicin-induced cardiotoxicity. Cao Y; Shen T; Huang X; Lin Y; Chen B; Pang J; Li G; Wang Q; Zohrabian S; Duan C; Ruan Y; Man Y; Wang S; Li J Oncotarget; 2017 Jan; 8(3):4837-4848. PubMed ID: 27902477 [TBL] [Abstract][Full Text] [Related]
47. Reversal of acquired drug resistance in FLT3-mutated acute myeloid leukemia cells via distinct drug combination strategies. Zhang W; Gao C; Konopleva M; Chen Y; Jacamo RO; Borthakur G; Cortes JE; Ravandi F; Ramachandran A; Andreeff M Clin Cancer Res; 2014 May; 20(9):2363-74. PubMed ID: 24619500 [TBL] [Abstract][Full Text] [Related]
48. Tyrosine kinase inhibitors - a review on pharmacology, metabolism and side effects. Hartmann JT; Haap M; Kopp HG; Lipp HP Curr Drug Metab; 2009 Jun; 10(5):470-81. PubMed ID: 19689244 [TBL] [Abstract][Full Text] [Related]
49. Preclinical approaches to assess potential kinase inhibitor-induced cardiac toxicity: Past, present and future. Yang B; Papoian T J Appl Toxicol; 2018 Jun; 38(6):790-800. PubMed ID: 29369373 [TBL] [Abstract][Full Text] [Related]
50. Heat shock transcription factor-1 inhibits H2O2-induced apoptosis via down-regulation of reactive oxygen species in cardiac myocytes. Zhang L; Jiang H; Gao X; Zou Y; Liu M; Liang Y; Yu Y; Zhu W; Chen H; Ge J Mol Cell Biochem; 2011 Jan; 347(1-2):21-8. PubMed ID: 20941531 [TBL] [Abstract][Full Text] [Related]
51. A novel compound DT-010 protects against doxorubicin-induced cardiotoxicity in zebrafish and H9c2 cells by inhibiting reactive oxygen species-mediated apoptotic and autophagic pathways. Tang F; Zhou X; Wang L; Shan L; Li C; Zhou H; Lee SM; Hoi MP Eur J Pharmacol; 2018 Feb; 820():86-96. PubMed ID: 29229534 [TBL] [Abstract][Full Text] [Related]
52. Peroxiredoxin-1 Overexpression Attenuates Doxorubicin-Induced Cardiotoxicity by Inhibiting Oxidative Stress and Cardiomyocyte Apoptosis. Jiang L; Gong Y; Hu Y; You Y; Wang J; Zhang Z; Wei Z; Tang C Oxid Med Cell Longev; 2020; 2020():2405135. PubMed ID: 32802259 [No Abstract] [Full Text] [Related]
53. Sorafenib induces cardiotoxicity through RBM20-mediated alternative splicing of sarcomeric and mitochondrial genes. Liu S; Yue S; Guo Y; Han JY; Wang H Pharmacol Res; 2023 Dec; 198():107017. PubMed ID: 38006979 [TBL] [Abstract][Full Text] [Related]
54. Involvement of mitogen activated kinase kinase 7 intracellular signalling pathway in Sunitinib-induced cardiotoxicity. Cooper SL; Sandhu H; Hussain A; Mee C; Maddock H Toxicology; 2018 Feb; 394():72-83. PubMed ID: 29248607 [TBL] [Abstract][Full Text] [Related]